Pfizer’s talks to acquire botox-maker Allergan in a $150bn (€140.8bn) deal, the global drug industry’s largest ever, that would see the US drug giant re-domicile in Ireland accelerated yesterday, even as the US Treasury prepared to clamp down further on such tax inversions.